{"DataElement":{"publicId":"2590423","version":"1","preferredName":"Engraftment Syndrome Skin Rash Body Surface Area Present Percentage Value","preferredDefinition":"the value, in percent, of involved body surface area, the measure of the 2-dimensional extent of the body surface, of a skin rash, any change in color or texture of the skin, being present as evidence of engraftment syndrome, a toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment.","longName":"ENGR_SK_BSA_PRE_IND","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2590385","version":"1","preferredName":"Engraftment Syndrome Skin Rash Body Surface Area Present","preferredDefinition":"information related to the involved body surface area,  the measure of the 2-dimensional extent of the body surface, of a skin rash, any change in color or texture of the skin, being present as evidence of engraftment syndrome, a toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment.","longName":"ENGRFT_SKIN_BSA_PRES","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2589945","version":"1","preferredName":"Engraftment Syndrome","preferredDefinition":"A toxicity of hematopoietic stem cell transplantation\r\nthat manifests as fever, rash and pulmonary deterioration which becomes\r\nevident at marrow engraftment. It occurs unexpectedly and is\r\noccasionally fatal. It can occur after an autogeneic or an allogeneic\r\nhematopoietic cell transplantation.","longName":"C63324","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Engraftment Syndrome","conceptCode":"C63324","definition":"A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"27A4B5A7-6417-28F4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-22","modifiedBy":"ONEDATA","dateModified":"2007-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2590383","version":"1","preferredName":"Skin Rash BSA Present","preferredDefinition":"No value exists.:A measure of the 2-dimensional exent of the body surface.:Being or existing in a specified place or at the specified time.","longName":"C39594:C25157:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Body Surface Area","conceptCode":"C25157","definition":"A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27B78A61-66AB-4E4B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-23","modifiedBy":"ONEDATA","dateModified":"2007-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27B78A61-66BC-4E4B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180234","version":"1","preferredName":"Lab Percentage Value","preferredDefinition":"the value as a percentage of 100.","longName":"LAB_PTG_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D173674B-2AF0-17B7-E034-0003BA12F5E7","latestVersionIndicator":"No","beginDate":"2004-01-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-21","modifiedBy":"CAMPBELB","dateModified":"2020-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Body Surface Area involvement","type":"Preferred Question Text","description":"Body Surface Area involvement","url":null,"context":"NHLBI"},{"name":"Specify amount of body surface area affected:","type":"Alternate Question Text","description":"Specify amount of body surface area affected:","url":null,"context":"NHLBI"},{"name":"Specify the percentage amount of body surface area affected by skin rash:","type":"Alternate Question Text","description":"Specify the percentage amount of body surface area affected by skin rash:","url":null,"context":"NHLBI"}],"origin":"Transplant CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"27BA4385-F62F-3C31-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-23","modifiedBy":"KUMMEROA","dateModified":"2021-08-23","changeDescription":"Alt name \"engraft_syndrm_rash_pct\"  removed due to being used on CDE 3061213. AK 7/26/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}